S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0070
-0.0002 (-2.78%)
Sep 2, 2026, 5:29 PM CET
S2Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -10.07 | -10.09 | 4.81 | -22.71 | -29.46 | -20.08 |
Depreciation & Amortization | 0.57 | 0.66 | 0.69 | 1.13 | 1.32 | 1.11 |
Other Amortization | 0.62 | 0.62 | 0.62 | 0.61 | 0.59 | 0.39 |
Other Operating Activities | 8.11 | 7.38 | -1.5 | -0.04 | -0.15 | 0.23 |
Change in Accounts Receivable | 0.24 | 1.42 | 1.6 | -0.13 | 0.34 | -0.5 |
Change in Inventory | 0.33 | 0.31 | 3.48 | 1.23 | -1.77 | -0.09 |
Change in Other Net Operating Assets | -0.25 | 0.39 | -4.67 | 3.39 | 0.89 | -0.72 |
Operating Cash Flow | -0.44 | 0.68 | 5.03 | -16.52 | -28.23 | -19.67 |
Operating Cash Flow Growth | - | -86.56% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | - | -0.11 | -0.19 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.14 | 0.07 |
Sale (Purchase) of Intangibles | -1.53 | -2.02 | - | -1.15 | -1.79 | -2.91 |
Investing Cash Flow | -1.53 | -2.02 | - | -1.15 | -1.76 | -3.02 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | 9.05 | 2.5 | 10 |
Long-Term Debt Repaid | - | - | -9.1 | -10.88 | -0.21 | -0.62 |
Net Debt Issued (Repaid) | - | - | -9.1 | -1.83 | 2.29 | 9.38 |
Issuance of Common Stock | 1.25 | 1.25 | 3.63 | 22 | 22.51 | - |
Other Financing Activities | - | - | -0.07 | -4.7 | -0.67 | -2.53 |
Financing Cash Flow | 1.25 | 1.25 | -5.54 | 15.47 | 24.14 | 6.85 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | 0.1 | - |
Net Cash Flow | -0.72 | -0.1 | -0.51 | -2.21 | -5.76 | -15.84 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.44 | 0.68 | 5.03 | -16.52 | -28.34 | -19.85 |
Free Cash Flow Growth | - | -86.56% | - | - | - | - |
Free Cash Flow Margin | -3.14% | 4.19% | 34.28% | -213.89% | -460.08% | -186.70% |
Free Cash Flow Per Share | - | 0.00 | 0.01 | -0.14 | -1.19 | -1.34 |
Levered Free Cash Flow | -1.23 | -0.3 | -6.47 | -10.99 | -16.38 | -7.61 |
Unlevered Free Cash Flow | -1.23 | -0.29 | -6.46 | -6.33 | -15.28 | -7.46 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.01 | 0.01 | 0.02 | 7.44 | 1.77 | 0.03 |
Cash Income Tax Paid | - | -0.17 | - | 0.04 | 0.05 | -0.04 |
Change in Working Capital | 0.32 | 2.12 | 0.41 | 4.49 | -0.54 | -1.31 |